A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors
Article in Exploration of Targeted Anti-tumor Therapy (August 2022)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Exploration of Targeted Anti-tumor Therapy (August 2022)
Article in Biochemical Pharmacology (March 2021)
Article in Blood (November 2020)